Apricus Biosciences

Apricus plummets after ED drug rejection
Biopharma Dive
Fri, 02/16/18 - 09:31 pm
Apricus Biosciences
FDA
erectile dysfunction
Vitaros
Apricus Biosciences Sells ED Therapy Rights
Investopedia
Fri, 03/10/17 - 09:46 am
Apricus Biosciences
erectile dysfunction
Ferring
Vitaros
Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Greece
Cafepharma/Globe Newswire
Wed, 10/26/16 - 09:11 am
Apricus Biosciences
Vitaros
erectile dysfunction
Greece
Top 6 Biopharma Movers of the Past Week
24/7 Wall St
Mon, 04/4/16 - 07:56 am
Genocea Biosciences
OPKO Health
ContraVir
Inovio
Acadia
Apricus Biosciences
Apricus shares are routed after testosterone drug fails to deliver clinical benefits
Fierce Biotech
Mon, 03/28/16 - 09:14 pm
Apricus Biosciences
testosterone
fispemifene
5 Big FDA Decisions Expected in September
24/7 Wall St
Sun, 08/30/15 - 02:08 pm
FDA
rolapitant
OPKO Health
Tesaro
Zosano
ZP-Glucagon
XenoPort
XP23829
Apricus Biosciences
RayVa
The Success Of Addyi And Sprout May Reward Investors In Apricus Bio And Femprox
Seeking Alpha
Sun, 08/23/15 - 11:45 am
Addyi
Sprout Pharmaceuticals
female sexual dysfunction
Apricus Biosciences
Femprox
Apricus Biosciences And Vivus: A Potential Golden Marriage
Seeking Alpha
Wed, 06/17/15 - 10:44 am
Vivus
Apricus Biosciences
M&A
Apricus Biosciences granted national phase approval for Vitaros in Luxembourg
The Fly on the Wall
Thu, 04/3/14 - 09:19 am
Apricus Biosciences
erectile dysfunciton
Vitaros
Luxembourg
Apricus' Loss Narrows in Q4
Yahoo/Zacks.com
Thu, 03/20/14 - 05:51 pm
Apricus Biosciences
earnings
2014 Could Be A Transformative Year For Apricus Biosciences
Seeking Alpha
Tue, 02/18/14 - 09:11 am
Apricus Biosciences
Vitaros
erectile dysfunction
Femprox
female sexual dysfunction
Apricus Biosciences expects to announce additional Vitaros partnerships
The Fly on the Wall
Tue, 11/26/13 - 08:52 am
Apricus Biosciences
Vitaros
Targeting An Untapped Female Sexual Dysfunction Drug Market
Seeking Alpha
Tue, 09/3/13 - 11:23 am
female sexual dysfunction
Osphena
Shionogi
flibanserin
Sprout Pharmaceuticals
bremelanotide
Palatin
Femprox
Apricus Biosciences
Will Big Changes At Apricus Biosciences Make It A Winning Stock?
Seeking Alpha
Mon, 07/1/13 - 12:47 pm
Apricus Biosciences
RayVa
MycoVa
Vitaros
Femprox
Apricus Biosciences announces sale of non-core assets
Yahoo/Fly on the Wall
Tue, 04/2/13 - 10:07 am
Apricus Biosciences
NitroMist
Biocodex
Totect
Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer
Yahoo
Tue, 03/19/13 - 10:52 am
Apricus Biosciences
Apricus Biosciences buying CSO to support European sales push
Outsourcing Pharma
Thu, 06/21/12 - 08:04 am
CSO
M&A
Apricus Biosciences
France
Europe
contract sales
Scomedica
Apricus Biosciences submits response for Vitaros market application
Yahoo/Fly on the Wall
Thu, 06/14/12 - 01:16 pm
Apricus Biosciences
Vitaros
Switzerland
erectile dysfunction
Apricus Biosciences granted pre-NDS meeting for Femprox
Yahoo/Fly on the Wall
Mon, 05/7/12 - 11:11 am
Apricus Biosciences
Femprox
Canada
Apricus Biosciences Announces Poster Presentation of Femprox Phase III Clinical Data at American Urological Association Annual Meeting
Pharmalive
Sat, 05/5/12 - 02:12 pm
Femprox
Apricus Biosciences
female sexual dysfunction

Pages